Photochemotherapy

Research in photochemotherapy explores the use of light and photosensitizing drugs to treat diseases, primarily cancer. Investigations focus on developing novel photosensitizers, understanding their mechanisms of action, and optimizing light delivery systems for targeted therapeutic effects. This includes synthesizing new molecules, evaluating their photophysical properties, and assessing their efficacy in preclinical models. Studies also examine the photodynamic processes involved, such as the generation of reactive oxygen species, and investigate ways to improve drug delivery and enhance treatment outcomes.

This work has direct relevance to Arkansas's public health by addressing the significant burden of cancer within the state. Developing more effective and less toxic cancer therapies aligns with improving patient outcomes and reducing healthcare costs. Furthermore, the synthesis of new chemical compounds and nanomaterials has potential applications in the state's growing biotechnology and advanced materials sectors, fostering innovation and economic development.

This area of study draws on expertise in pharmacology, drug delivery systems, and nanomaterials. Researchers collaborate across institutions within Arkansas, leveraging strengths in analytical chemistry, medical research, and materials science to advance photochemotherapy applications.